retatrutide cagrilintide Cagrilintide, Tirzepatide, and Peptides: Comparing Metabolic Mechanisms Retatrutide vs CagriSema: The Battle
Description
Retatrutide Phase 3 Studies
Semaglutide is formulated and approved only for subcutaneous injection
They reflect natural physiological adaptation rather than treatment failure
One smaller study (169) (12 participants) showed increased postprandial glycemia with ARNI compared to placebo which contradicts a huge PARADIGM-HF trial (170)
